We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+1.47%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$14.6B
AUM Growth
+$1.71B
(+13%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
10.84%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
856
New
17
Increased
646
Reduced
63
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$52.7M |
| 2 |
ExxonMobil
XOM
|
+$47.8M |
| 3 |
Cisco
CSCO
|
+$37.5M |
| 4 |
Ford
F
|
+$36.3M |
| 5 |
Johnson & Johnson
JNJ
|
+$35.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UGI
UGI
|
+$35.5M |
| 2 |
QGENF
QIAGEN NV
QGENF
|
+$34.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$26.5M |
| 4 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$25.5M |
| 5 |
AMT.PRA
American Tower Corporation
AMT.PRA
|
+$20.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.27% |
| 2 | Technology | 13.75% |
| 3 | Healthcare | 13.38% |
| 4 | Industrials | 9.06% |
| 5 | Consumer Discretionary | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
BioMarin Pharmaceuticals
BMRN
$12.3B
| $10.2M | 0.07% |
81,556
+24,623
| +43% | +$2.61M |
|
302
Edwards Lifesciences
EW
$51.7B
| $10.1M | 0.07% |
427,254
+6
| +0% | +$135 |
|
303
Monster Beverage
MNST
$88.4B
| $10.1M | 0.07% |
439,644
+105,840
| +32% | +$2.22M |
|
304
Constellation Brands
STZ
$23.2B
| $10.1M | 0.07% |
87,258
+20,639
| +31% | +$2.32M |
|
|
MXIM
305
DELISTED
Maxim Integrated Products
MXIM
| $10.1M | 0.07% |
290,588
+35,834
| +14% | +$1.22M |
|
306
Vornado Realty Trust
VNO
$7.38B
| $10.1M | 0.07% |
111,483
+16,815
| +18% | +$1.51M |
|
307
Sun Life Financial
SLF
$45.4B
| $10M | 0.07% |
326,470
+75,038
| +30% | +$2.4M |
|
308
Bread Financial
BFH
$4.38B
| $10M | 0.07% |
42,413
+14,353
| +51% | +$3.28M |
|
309
WEC Energy
WEC
$35.1B
| $9.98M | 0.07% |
201,658
+63,910
| +46% | +$3.34M |
|
310
Stanley Black & Decker
SWK
$15.7B
| $9.91M | 0.07% |
103,943
+2,177
| +2% | +$208K |
|
311
Cheniere Energy
LNG
$52.9B
| $9.91M | 0.07% |
128,009
+29,877
| +30% | +$2.23M |
|
|
TYC
312
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $9.87M | 0.07% |
218,867
+41,918
| +24% | +$1.87M |
|
313
Intuitive Surgical
ISRG
$134B
| $9.86M | 0.07% |
175,626
+42,642
| +32% | +$2.41M |
|
314
Trane Technologies
TT
$106B
| $9.85M | 0.07% |
144,697
+32,621
| +29% | +$2.15M |
|
315
DTE Energy
DTE
$29.1B
| $9.78M | 0.07% |
142,430
-1,000
| -0.7% | -$71.8K |
|
|
MRO
316
DELISTED
Marathon Oil Corporation
MRO
| $9.77M | 0.07% |
374,216
+28,066
| +8% | +$761K |
|
317
Host Hotels & Resorts
HST
$16B
| $9.76M | 0.07% |
483,470
+33,947
| +8% | +$758K |
|
318
Amphenol
APH
$209B
| $9.75M | 0.07% |
661,872
+141,832
| +27% | +$1.99M |
|
|
SPLS
319
DELISTED
Staples Inc
SPLS
| $9.71M | 0.07% |
596,142
+78,002
| +15% | +$1.31M |
|
|
CTXS
320
DELISTED
Citrix Systems Inc
CTXS
| $9.66M | 0.07% |
189,871
+105,417
| +125% | +$5.19M |
|
321
iShares MSCI Indonesia ETF
EIDO
$501M
| $9.62M | 0.07% |
346,700
-1,100
| -0.3% | -$29.9K |
|
|
COL
322
DELISTED
Rockwell Collins
COL
| $9.61M | 0.07% |
99,576
+23,268
| +30% | +$2.08M |
|
323
Ovintiv
OVV
$16.4B
| $9.54M | 0.07% |
171,312
+18,336
| +12% | +$1.15M |
|
324
Marriott International
MAR
$92.3B
| $9.52M | 0.07% |
118,569
+24,164
| +26% | +$1.93M |
|
325
Weyerhaeuser
WY
$18.4B
| $9.52M | 0.07% |
287,122
+55,513
| +24% | +$1.94M |
|
Similar funds
QCM
NAMI
Aviva's Q1 2015 Portfolio in Review
As of Q1 2015, Aviva held 856 positions worth $14.6B, up 13% from $12.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Aviva deployed $1.58B of net new capital in Q1 2015, opening 17 new positions and adding to 646 existing holdings. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 14,000 shares worth $14.4M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was UGI, an estimated $35.5M trimmed.
- Aviva's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 14,000 shares worth $14.4M.
- Aviva added most to Apple in Q1 2015, an estimated $52.7M increase.
- Aviva's biggest Q1 2015 reduction was UGI, cutting an estimated $35.5M.
- Aviva fully exited Allergan Inc in Q1 2015, selling an estimated $26.5M.
- Aviva's ten largest holdings make up 15% of its $14.6B portfolio in Q1 2015.
- Aviva opened 17 new positions and closed 34 in Q1 2015.
- Aviva's portfolio value rose 13% quarter-over-quarter to $14.6B.
Based on Aviva's 13F filing for Q1 2015, filed 14 May 2015.